Screener
PharmaCyte Biotech, Inc. PMCB Q3 2026 earnings
Reported September 14, 2026 · Before market open
EPS-$0.54Miss by $0.48
EPS estimate-$0.06
Next report
Dec 16, 2026 (in a month)EPS estimate-$0.06
Versus estimates
Diluted EPS
Q3 2026-$0.54Miss by $0.48
Q2 2026-$0.54Miss by $0.48Q1 2026$0.13Beat by $0.19Q4 2025-$0.32Q3 2025-$0.09Q2 2025$1.73FAQ
- When did PharmaCyte Biotech, Inc. report Q3 2026 earnings?
- PharmaCyte Biotech, Inc. (PMCB) reported Q3 2026 earnings on September 14, 2026 before market open.
- What were PharmaCyte Biotech, Inc.'s Q3 2026 revenue and EPS?
- PharmaCyte Biotech, Inc. reported eps of $-0.54 for Q3 2026.
- Did PharmaCyte Biotech, Inc. beat estimates in Q3 2026?
- EPS missed the consensus estimate of $-0.06 by $0.48.
- How did PharmaCyte Biotech, Inc.'s Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 500.0% from $-0.09.
- Where can I find PharmaCyte Biotech, Inc.'s Q3 2026 SEC filings?
- You can read the 10-Q periodic report (0001683168-26-007106) directly on SEC EDGAR. The filing index links above go to sec.gov.
